AQB: financial statements from SEC

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	—	—	—	—	47,812	180,182
Cost of revenue	—	—	—	—	425,057	2M
Research and development	—	—	—	—	70,300	76,766
Selling, general and administrative	621,566	1M	2M	2M	2M	3M
Operating expenses	621,566	1M	3M	1M	2M	30M
Operating income	−621,566	−1M	−3M	−1M	−2M	−30M
Net income	−1M	−1M	−3M	401,135	−3M	−51M
Earnings per share	−0.26	−0.36	−0.87	0.10	−0.88	−13.08
Earnings per share, diluted	−0.26	−0.36	−0.87	0.10	−0.88	−13.08
Weighted average shares	5M	4M	4M	4M	4M	4M
Weighted average shares, diluted	5M	4M	4M	4M	4M	4M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	440,678	501,295	951,434	729,569	1M	230,362	500,434	728,339
Inventory	—	—	—	—	—	—	466,270	124,916
Current assets	10M	10M	1M	4M	7M	11M	37M	37M
Property, plant and equipment	—	—	23M	23M	23M	23M	80M	90M
Total assets	10M	10M	24M	27M	29M	34M	118M	127M
Current liabilities	9M	9M	12M	13M	12M	16M	12M	19M
Short-term debt	—	—	8M	9M	1M	1M	349,312	5M
Long-term debt	4M	3M	—	—	—	2M	5M	5M
Total liabilities	12M	12M	12M	13M	12M	18M	18M	24M
Equity	−2M	−2M	12M	14M	17M	16M	100M	103M
Shares outstanding	5M	4M	4M	4M	4M	4M	4M	4M
Shares issued	5M	4M	—	—	—	4M	—	—